HonorHealth's Cancer Research Program: A Leader in Clinical Trials and Treatment Innovation

HonorHealth's cancer research program at the HonorHealth Research Institute is recognized as an international leader in the fight against cancer. The program is distinguished by its focus on developing new cancer drugs and expediting their FDA approval, thereby transforming cancer treatment globally.

Patients enrolled in the program have the opportunity to participate in clinical trials ranging from phase I to phase IV, with a particular emphasis on early drug development. This offers several benefits, including early access to new medications or treatment approaches, close monitoring by healthcare professionals, and comprehensive support from a dedicated navigator throughout the treatment process.

Additionally, the program provides a concierge service to assist patients and their families with questions and referrals, alongside a variety of services and resources through HonorHealth Cancer Care. These include genetic counseling and testing, patient and family support groups, Tina's Treasures cancer patient boutique, and body, mind, and spirit programs.

Newly diagnosed patients within HonorHealth Cancer Care are screened for eligibility to participate in clinical trials, which are available at any stage of the cancer journey. This initiative not only benefits patients from Arizona and across the U.S. but also attracts participants from other countries.

Since its inception in 2005, HonorHealth's cancer research program has forged significant partnerships with leading universities, nonprofit organizations, and medical device and drug companies. These collaborations have contributed to the program's remarkable achievements in cancer research, further solidifying its position as a leader in the field.